Efficacy and Safety of StENt-assisted Treatment for CErebral Aneurysms

Kobe City General Hospital500 enrolled

Overview

Prospective registry study to evaluate safety and efficacy of stent assisted embolization of intracranial aneurysm.

To evaluate stent assisted embolization of intracranial aneurysm, record information about treatment and any event (death, stroke, hemorrhagic event) prospectively.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Stent Embolisation

Interventions

stent assisted embolizationPROCEDURE

stent assisted embolization and anti-thrombotic management

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * stent assisted embolization of intracranial aneurysm * 20 or more year old Exclusion Criteria: * not determined

Locations (1)

Kobe City Medical Center General Hospital

Kobe, Hyōgo, Japan

RECRUITING

Outcomes

Primary Outcomes

any death, stroke and major hemorrhagic event

any death, stroke and major hemorrhagic event within 2 years after treatment

Time frame: 2 years after treatment

Secondary Outcomes

any adverse event

1. death, stroke, hemorrhagic event within 30days or between 31days to 2years after treatment 2. any change of anti-thrombotic therapy within 2years after treatment 3. recanalization or re-treatment within 2years after treatment 4. stent stenosis or occlusion within 2years after treatment 5. any adverse event within 2years after treatment

Time frame: 2 years

Central Contacts

Nobuyuki Sakai, MD, DMSc

CONTACT

81783024321 n.sakai@siren.ocn.ne.jp

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.